Replies to post #252373 on Biotech Values

[dewophile]

MRNA is going to talk RSV/flu/Covid combo as a pitch in favor of annual dosing (making their RSV shot potentially more efficacious in theory at the 18-24 month mark than PFE/GSK as their efficacy starts to wane in season 2)
At least that is how I would spin it